Zhang YY - Search Results

1

Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer.

Zhao CC, Zhan MN, Liu WT, Jiao Y, Zhang YY, Lei Y, Zhang TT, Zhang CJ, Du YY, Gu KS, Wei W. Zhao CC, et al. Among authors: zhang cj, zhang yy, zhang tt. Cancer Lett. 2020 Nov 28;493:120-127. doi: 10.1016/j.canlet.2020.08.006. Epub 2020 Aug 21. Cancer Lett. 2020. PMID: 32829006

2

DNA repair capacity in peripheral blood lymphocytes predicts efficacy of platinum-based chemotherapy in patients with gastric cancer.

Zhang YY, Gu KS. Zhang YY, et al. Asian Pac J Cancer Prev. 2013;14(9):5507-12. doi: 10.7314/apjcp.2013.14.9.5507. Asian Pac J Cancer Prev. 2013. PMID: 24175850 Free article.

3

Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.

Zhang Y, Wu H, Yang F, Ning J, Li M, Zhao C, Zhong S, Gu K, Wang H. Zhang Y, et al. Am J Pathol. 2018 Feb;188(2):367-377. doi: 10.1016/j.ajpath.2017.10.010. Epub 2018 Jan 10. Am J Pathol. 2018. PMID: 29331492 Free PMC article.

4

miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.

Ning J, Jiao Y, Xie X, Deng X, Zhang Y, Yang Y, Zhao C, Wang H, Gu K. Ning J, et al. Oncol Rep. 2019 Feb;41(2):1131-1139. doi: 10.3892/or.2018.6907. Epub 2018 Dec 6. Oncol Rep. 2019. PMID: 30535472

5

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.

Xie X, Huang N, Zhang Y, Wei X, Gao M, Li M, Ning J, Liu W, Zhao Q, Wang H, Gu K. Xie X, et al. J Cancer. 2019 Jan 29;10(4):1039-1051. doi: 10.7150/jca.25814. eCollection 2019. J Cancer. 2019. PMID: 30854110 Free PMC article.

6

Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.

Zhao CC, Jiao Y, Zhang YY, Ning J, Zhang YR, Xu J, Wei W, Kang-Sheng G. Zhao CC, et al. Among authors: zhang yr, zhang yy. Cell Death Dis. 2019 Mar 15;10(4):252. doi: 10.1038/s41419-019-1479-3. Cell Death Dis. 2019. PMID: 30874550 Free PMC article.

7

Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis.

Zhang F, Zhang Y, Jia Z, Wu H, Gu K. Zhang F, et al. J Cancer. 2019 Apr 25;10(8):1923-1929. doi: 10.7150/jca.28896. eCollection 2019. J Cancer. 2019. PMID: 31205551 Free PMC article.

8

MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway.

Li M, Gao M, Xie X, Zhang Y, Ning J, Liu P, Gu K. Li M, et al. Oncol Lett. 2019 Jul;18(1):145-152. doi: 10.3892/ol.2019.10304. Epub 2019 May 2. Oncol Lett. 2019. PMID: 31289483 Free PMC article.

9

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.

Wei X, Gao M, Ahmed Y, Gao M, Liu W, Zhang Y, Xie X, Zhao Q, Wang H, Gu K. Wei X, et al. Oncol Lett. 2019 Aug;18(2):1607-1616. doi: 10.3892/ol.2019.10496. Epub 2019 Jun 19. Oncol Lett. 2019. PMID: 31423228 Free PMC article.

10

Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer.

Liu WT, Liu WB, Gao M, Zhang YY, Gu KS. Liu WT, et al. Among authors: zhang yy. Oncol Lett. 2019 Nov;18(5):4573-4582. doi: 10.3892/ol.2019.10798. Epub 2019 Sep 4. Oncol Lett. 2019. PMID: 31611965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,234 results

Search Page

Filters